{"id":"NCT02810457","sponsor":"Centus Biotherapeutics Limited","briefTitle":"Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer","officialTitle":"A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients With Advanced/Recurrent Non Squamous NSCLC in Combination of Paclitaxel and Carboplatin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-07","primaryCompletion":"2019-01-24","completion":"2022-01-26","firstPosted":"2016-06-23","resultsPosted":"2020-03-19","lastUpdate":"2022-03-10"},"enrollment":731,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"interventions":[{"type":"DRUG","name":"FKB238 (bevacizumab)","otherNames":[]},{"type":"DRUG","name":"Avastin (bevacizumab)","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]}],"arms":[{"label":"FKB238 / paclitaxel / carboplatin","type":"EXPERIMENTAL"},{"label":"Avastin / paclitaxel / carboplatin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this research study is to compare the effectiveness and safety of FKB238 against Avastin® in men and women with advanced/recurrent non squamous non-small cell lung cancer","primaryOutcome":{"measure":"Overall Response Rate (ORR) Assessed as the Proportion of Patients With a Best Overall Response (BOR) of Either Complete Response (CR) or Partial Response (PR)","timeFrame":"Until data cut-off, which occurred 12 months after randomization of the last patient enrolled, for a total estimated period of time of up to approximately 30 months.","effectByArm":[{"arm":"FKB238 / Paclitaxel / Carboplatin","deltaMin":51.6,"sd":null},{"arm":"Avastin / Paclitaxel / Carboplatin","deltaMin":53.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":147,"countries":["United States","Belarus","Bosnia and Herzegovina","Bulgaria","Croatia","Georgia","Germany","Greece","Hungary","Italy","Japan","Peru","Philippines","Poland","Romania","Russia","Serbia","South Korea","Spain","Taiwan","Thailand","Turkey (Türkiye)","Ukraine","Vietnam"]},"refs":{"pmids":["34264503"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":91,"n":362},"commonTop":["Alopecia","Neutropenia","Anaemia","Thrombocytopenia","Neuropathy peripheral"]}}